Kite and Daiichi Sankyo Announce Changes to YESCARTA® CAR T-Cell Therapy Licensing Agreement in Japan Pharmaceutical Investing
Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference Pharmaceutical Investing
U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer's Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV Disease in Older Adults Life Science Investing
New Data for Trodelvy Demonstrate Clinical Efficacy Across Trop-2 Expression Levels in HR+/HER2- Metastatic Breast Cancer Pharmaceutical Investing
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline Pharmaceutical Investing
Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease Life Science Investing
AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European Headache Federation Congress Pharmaceutical Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. , Imago BioSciences, Inc. , Opiant Pharmaceuticals Inc. , Benefitfocus, Inc. Life Science Investing
BetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology in Phoenix, Arizona Pharmaceutical Investing
Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day Life Science Investing
